HHRI News & Press Releases
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More